Merck & Co.

Public MRK · United States

FollowEvery new trial, moved date and filing, and a Monday email
Furthest along
15 approved
18 in Phase 3
Next date
pembrolizumab, Phase 3 trial completes
Drugs
68
in active trials · 197 in all
Trials
228 active
770 since 2021

Drugs68

DrugHow it worksPartnerStageNext dateDetails
PD-1 antibody
Approved 20 Nov 2026soonPhase 3 trial completes
TROP2-targeted antibody-drug conjugate
Kelun-Biotech
Approved in China Nov 2026soonPhase 3 trial completes
Hypoxia-inducible factor inhibitor
Approved 22 Dec 2026Phase 1/2 trial completes
—
Approved 15 Jan 2027Phase 3 trial completes
Kinase inhibitor
Eisai
Approved 22 Mar 2027Phase 2 trial completes
Azole antifungal
Approved 31 Mar 2027Phase 2 trial completes
Orexin receptor antagonist
Approved 24 Jun 2027Phase 3 trial completes
—
Approved 12 Oct 2027Phase 2 trial completes
Receptor molecules, native or modified
Approved 21 Mar 2028Phase 4 trial completes
—
Approved 31 Mar 2028Phase 3 trial completes
Cytomegalovirus DNA terminase complex inhibitor
Approved 14 Apr 2028Phase 1 trial completes
Human immunodeficiency virus 1 non-nucleoside analog reverse transcriptase inhibitor
Approved 12 Nov 2028Phase 2 trial completes
—
Approved 29 May 2029Phase 3 trial completes
Soluble guanylate cyclase stimulator
Approved 20 Aug 2029Phase 2/3 trial completes
—
Approved in other 26 Jan 2031Phase 3 trial completes
Artificial immunoglobulin
Phase 3 17 Feb 2027Phase 2 trial completes
Personalised mRNA cancer vaccine
Moderna
Phase 3 23 Apr 2027Phase 1/2 trial completes
Bruton's tyrosine kinase inhibitor
Phase 3 19 May 2027Phase 3 trial completes
—
Phase 3 14 Jul 2027Phase 3 trial completes
—
Phase 3 22 Jul 2027Phase 3 trial completes

See all 68 drugs

Sign in free to see the whole list. No card, no password.

Sign in free

SEC filings25

Since Feb 2024 · All on SEC.gov

About

No active trial
129 other drugs
Registry names
2 names in ClinicalTrials.gov
Sources
ClinicalTrials.gov updated 16 Nov 2026 · SEC filings Industry-sponsored drug trials since 2021 · Logos provided by Logo.dev

Follow Merck & Co.

Following is part of Solo: you see every change to Merck & Co. the day it happens.

Solo

$49a month

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in